A short course of metformin does not reduce OHSS in a GnRH antagonist cycle for women with PCOS undergoing IVF: a randomised placebo-controlled trial. (Q48536578)

From Wikidata

Jump to navigation Jump to search

scientific article published on 5 November 2016

Language	Label	Description	Also known as
English	A short course of metformin does not reduce OHSS in a GnRH antagonist cycle for women with PCOS undergoing IVF: a randomised placebo-controlled trial.	scientific article published on 5 November 2016

Statements

scholarly article

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/27816925

A short course of metformin does not reduce OHSS in a GnRH antagonist cycle for women with PCOS undergoing IVF: a randomised placebo-controlled trial. (English)

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/27816925

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

S L Jacob

1

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/27816925

C Brewer

2

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/27816925

T Tang

3

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/27816925

H M Picton

4

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/27816925

J H Barth

5

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/27816925

A H Balen

6

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/27816925

language of work or name

0 references

publication date

5 November 2016

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/27816925

Human Reproduction

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/27816925

31

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/27816925

12

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/27816925

2756-2764

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/27816925

GnRH antagonists are safer than agonists: an update of a Cochrane review.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography-tandem mass spectrometry and analysis by receiver operator characteristic plots

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

The adverse effects of obesity on conception and implantation

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Testosterone measurement by isotope-dilution liquid chromatography-tandem mass spectrometry: validation of a method for routine clinical practice

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

World Health Organization reference values for human semen characteristics

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Elective single embryo transfer: guidelines for practice British Fertility Society and Association of Clinical Embryologists

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Insulin action in the normal and polycystic ovary

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Metformin modulates IL-8, IL-1β, ICAM and IGFBP-1 expression in human endometrial stromal cells.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Human chorionic gonadotropin vs. gonadotropin-releasing hormone agonist trigger in assisted reproductive technology--"the king is dead, long live the king!".

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Dehydroepiandrosterone and metformin modulate progesterone-induced blocking factor (PIBF), cyclooxygenase 2 (COX2) and cytokines in early pregnant mice.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Blood organic mercury and dietary mercury intake: National Health and Nutrition Examination Survey, 1999 and 2000.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

The effect of metformin treatment in vivo on acute and long-term energy metabolism and progesterone production in vitro by granulosa cells from women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Distinction between early and late ovarian hyperstimulation syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Effects of metformin treatment on luteal phase progesterone concentration in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

The significance of the number of antral follicles prior to stimulation in predicting ovarian responses in an IVF programme.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Metformin treatment in patients with polycystic ovary syndrome undergoing in vitro fertilization: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

South Asian women with polycystic ovary syndrome exhibit greater sensitivity to gonadotropin stimulation with reduced fertilization and ongoing pregnancy rates than their Caucasian counterparts

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Effects of metformin in women with polycystic ovary syndrome treated with gonadotrophins for in vitro fertilisation and intracytoplasmic sperm injection cycles: a systematic review and meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Meta-analysis of GnRH antagonist protocols: do they reduce the risk of OHSS in PCOS?

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Influence of vitamin D levels on in vitro fertilization outcomes in donor-recipient cycles

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

The influence of dehydroepiandrosterone on early pregnancy in mice

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Poor prognosis with in vitro fertilization in Indian women compared to Caucasian women despite similar embryo quality

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

The pivotal role of glucose metabolism in determining oocyte developmental competence.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

IVF outcome in women with PCOS, PCO and normal ovarian morphology.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

The use of metformin for women with PCOS undergoing IVF treatment.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEW268

21 January 2018

Identifiers

10.1093/HUMREP/DEW268

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/27816925

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/27816925

2-s2.0-85014477555

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48536578&oldid=1294913620"